GlassScriptPhysician profile
Janel K Weaver
NPI 1255723805
$649.67
in general payments reported to CMS, 2019-2025
15 companies · $325 in 2025
The $325 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $159 · 2022: $58.11 · 2023: $17.71 · 2024: $89.65 · 2025: $325.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $433.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $432.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Madrigal Pharmaceuticals | $112.91 | 2025 | Rezdiffra |
| Kci USA, INC. | $94.39 | 2021-2023 | Activ.A.C. |
| Janssen Pharmaceuticals, INC | $66.06 | 2021 | |
| Smith+Nephew, INC. | $58.49 | 2024-2025 | Collagenase Santyl |
| Astrazeneca Pharmaceuticals LP | $54.07 | 2025 | Airsupra, Farxiga |
| Novo Nordisk INC | $47.70 | 2025 | Ozempic, Rybelsus |
| Organogenesis INC. | $38.74 | 2024 | |
| Abbvie INC. | $34.04 | 2025 | |
| Medline Industries LP | $31.42 | 2022 | |
| Hydrofera LLC | $26.69 | 2022 | |
| Exact Sciences Corporation | $19.75 | 2025 | Cologuard Collection Kit |
| Amgen INC. | $18.05 | 2025 | Prolia, Evenity |
| Solventum Corporation | $16.42 | 2024 | Activ.A.C., 3m Cavilon, Snap |
| Integra Lifesciences Corporation | $16.27 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $14.67 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janel Weaver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.